BetterScholar BetterScholar

E. Imel

Journal of Bone and Mineral Research, Journal of Clinical Endocrinology and Metabolism, Journal of musculoskeletal & neuronal interactions, Biochemical and Biophysical Research Communications - BBRC, New England Journal of Medicine, Journal of Clinical Investigation, The Lancet, Journal of the American Medical Association Show more
11
Role
Title
Level Year L/R
🐬 A clinician's guide to X‐linked hypophosphatemia
T. Carpenter, E. Imel, I. Holm, S. M. Jan de Beur, K. Insogna 		8 2011
8
🐬
🐜 A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.
10 auth. S. Ichikawa, E. Imel, M. Kreiter, X. Yu, D. Mackenzie, A. H. Sorenson, ... R. Goetz, M. Mohammadi, K. White, M. Econs 		8 2007
8
🐜
🐜 Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects.
21 auth. Y. Yamazaki, A. Imura, I. Urakawa, T. Shimada, J. Murakami, Yukiko Aono, H. Hasegawa, T. Yamashita, K. Nakatani, Yoshihiko Saito, ... N. Okamoto, N. Kurumatani, N. Namba, T. Kitaoka, K. Ozono, T. Sakai, H. Hataya, S. Ichikawa, E. Imel, M. Econs, Y. Nabeshima 		8 2010
8
🐜
🐜 Burosumab Therapy in Children with X‐Linked Hypophosphatemia
14 auth. T. Carpenter, M. Whyte, E. Imel, A. Boot, W. Högler, A. Linglart, R. Padidela, W. V. van’t Hoff, M. Mao, Chao‐Yin Chen, ... A. Skrinar, E. Kakkis, J. S. San Martin, A. Portale 		8 2018
8
🐜
🐜 Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.
12 auth. T. Carpenter, E. Imel, M. Ruppe, T. Weber, M. Klausner, M. Wooddell, ... Tetsuyoshi Kawakami, Takahiro Ito, Xiaoping Zhang, J. Humphrey, K. Insogna, M. Peacock 		8 2014
8
🐜
🦁 Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.
E. Imel, M. Peacock, A. Gray, Leah R. Padgett, S. Hui, M. Econs 		8 2011
8
🦁
🐜 A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis
21 auth. K. Insogna, K. Briot, E. Imel, P. Kamenickỷ, M. Ruppe, A. Portale, T. Weber, P. Pitukcheewanont, H. Cheong, S. M. Jan de Beur, ... Y. Imanishi, N. Ito, R. Lachmann, Hiroyuki Tanaka, Farzana Perwad, Lin Zhang, Chao‐Yin Chen, C. Theodore-Oklota, M. Mealiffe, J. S. San Martin, T. Carpenter 		7 2018
7
🐜
🦁 Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
23 auth. E. Imel, F. Glorieux, M. Whyte, C. Munns, L. Ward, O. Nilsson, J. Simmons, R. Padidela, N. Namba, H. Cheong, ... P. Pitukcheewanont, E. Sochett, W. Högler, K. Muroya, Hiroyuki Tanaka, G. Gottesman, A. Biggin, Farzana Perwad, M. Mao, Chao‐Yin Chen, A. Skrinar, Javier San Martin, A. Portale 		7 2019
7
🦁
🦁 Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
16 auth. E. Imel, M. Peacock, P. Pitukcheewanont, H. J. Heller, L. Ward, D. Shulman, M. Kassem, P. Rackoff, M. Zimering, A. Dalkin, ... E. Drobny, G. Colussi, J. Shaker, E. H. Hoogendoorn, S. Hui, M. Econs 		7 2006
7
🦁
🐜 Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
11 auth. M. Wolf, J. Rubin, Maureen M. Achebe, M. Econs, M. Peacock, E. Imel, ... L. Thomsen, T. Carpenter, T. Weber, V. Brandenburg, H. Zoller 		7 2020
7
🐜
🦁 FGF23 Concentrations Vary With Disease Status in Autosomal Dominant Hypophosphatemic Rickets
E. Imel, Siu L. Hui, Michael J Ecibs 		7 2007
7
🦁